Adrian R. Krainer's most recent trade in Stoke Therapeutics Inc was a trade of 7,639 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 7,639 | 7,639 | - | - | Director Stock Option (Right to Buy) | |
Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,441 | 19,441 | - | - | Director Stock Option (Right to Buy) | |
Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 21,000 | 21,000 | - | - | Director Stock Option (Right to Buy) | |
Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,650 | 11,650 | - | - | Director Stock Option (Right to Buy) | |
Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 14,777 | 14,777 | - | - | Director Stock Option (Right to Buy) |